Update on vaccines for 2019/20 seasonal flu vaccination programme
The National Flu Immunisation Programme 19/20 22 March Letter
Update on vaccines for 2019/20 seasonal flu vaccination programme NHS England has published an update on vaccines for 2019/20 seasonal flu vaccination programme. As stated previously, QIVe (18 to 64-year olds in clinical at-risk groups and other eligible groups, including frontline health and social care workers) and aTIV (65 years and over) remain recommended. In addition, QIVc (Flucelvax® Tetra), is now licensed for patients from the age of 9 and considered to be suitable for all patients eligible for QIVe and aTIV, meaning one vaccine instead of two. The high-dose trivalent vaccine (TIV-HD) has also been licensed but will not be reimbursed by NHS England due to its high cost.
Practices should order the licensed vaccines (aTIV, QIVe and QIVc) for the 2019/20 season. Read the letter here.
